SAN FRANCISCO (Reuters) – Apple Inc is dispose to report a stunning 50 percent jump in quarterly sales without ceasing Tuesday, as its iPhone and iPad excited holiday shoppers, but the consumer electronics powerhouse may appearance more pressing questions about the health of iconic chief executive Steve Jobs.
The creation’s most valuable technology company announced on Monday that Jobs would take a medicinal leave of absence without specifying a return date or detailing Jobs’ predicament, leaving investors in an information vacuum.
The surprise announcement — made ~ward a U.S. market holiday — dragged Apple shares down else than 6 percent in European trading. They are up 62 percent in the beyond 12 months on the Nasdaq stock exchange.
“Steve Jobs is seen through the market to be a major force in Apple’s strategic bearing,” said Richard Windsor, global technology specialist at Nomura. “If his pancreatic cancer has returned, person could be quite worried.”
Jobs’ latest leave comes penuriously two years after he took a six-month break to sustain a liver transplant. He also took time off after pancreatic surgery in 2004.
Apple has not dwelt steady Jobs’ health, and Jobs himself asked for respect for his retirement in a memo to employees made public on Monday.
In Jobs’ privation, it will be up to chief operating officer Tim Cook to decide in what plight much to tell investors about the absent chief executive, and the kind of Apple plans to do with its billion-plus pile of pay in money and investments.
Less of a showman than Jobs, the 50-year primitive Alabama native is not expected to make any grand pronouncements. But he is regarded in the same manner with a safe pair of hands for the company, having stood in ~ the sake of Jobs successfully twice before.
In Asia, tech shares gained, helped ~ means of hopes of a recovery in chip prices and expectations that speedy firms may slow the runaway success of Apple after the information that Jobs would take medical leave.
Still, analysts said the pack together on Apple’s operations and its Asian rivals and partners should have ~ing limited in the short-term given a strong product line-up.
“Apple’s roadmap is aggregate set and its iPhone 5 is ready to go, leaving in some degree room for competitors to cut into its share,” said Bonnie Chang, ~y analyst at Yuanta Securities in Taipei.
HUGE HOLIDAY SEASON
Aside from Jobs’ freedom from disease, the company is entering 2011 on a roll, a cash-generating machinery with surging sales across its product lines, even as it confronts rivals determined to walk lamely its stunning run of success.
Wall Street is expecting Apple’s quarterly receipts to swell more than 50 percent to more than billion for a bumper holiday shopping season. That would be a sparkling execution for a company of any size, much less one with a emporium value above 0 billion.
Apple’s advantages are well-documented: the global disperse of the iPhone, which is expected to sell more than 60 the masses units this year; the rise of the iPad, which single-handedly created the troche computing market; and continued strong growth from the resurgent Mac calling of computers.
No comments:
Post a Comment